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Background
The bacteriophage P22 protein cage can be bioengineered
to contain a high-relaxivity gadolinium (Gd) payload
internally and targeting ligands externally. It also enables
phage-library-based identification of novel targets. Thus,
P22 may have advantages for molecular/cellular imaging
by MRI.
Methods
1) P22: The P22 protein cage (60 nm) is bioengineered
with an internal polymer network with amine functional
groups allowing incorporation of ~9100 Gd-DTPA mole-
cules per cage via the amine groups (Figure 1: [1]). This
provides a per cage relaxivity of 70000 mM-1s-1, superior
to Gd-DTPA for the equivalent Gd concentration.
2) Atherosclerosis Models: Both ApoE-deficient
(ApoE-/-) and FVB mice were used. ApoE-/- mice develop
atherosclerosis enhanced by high-fat diet. FVB mice
develop macrophage-rich carotid lesions with carotid
ligation in combination with high-fat diet and diabetes
induction [2].
3) P22-polymer-Gd in vivo MR imaging: Mice were
injected intravenously with P22-polymer-Gd (N=5, 20
µmol Gd/kg, one-fifth the typical clinical dose) or Mag-
nevist (N=1, 20 µmol Gd/kg). Vascular MRA at 1T was
performed (Aspect M2TM, 500 mT/m, 2500 T/m/s) using
3D-SPGR (TR/TE=12 ms/2.1 ms, slice thickness=1 mm,
FOV=5 cm, matrix=128x128, FA=45). Vessel wall MRI at
3T was performed (Signa HDx, GE Healthcare, 50mT/m,
150 T/m/s) with a phased-array mouse coil (RAPID MR
International), using a double inversion recovery fast spin
echo sequence (TR/TE= 400 ms/15 ms, slice thick-
ness=1mm, FOV=3 cm, matrix= 256x256) up to 24
hours after injection.
4) RGD-targeted P22 ex vivo fluorescence imaging:
Molecular targeting of P22 was evaluated by attaching
RGD peptides externally, which targets the aVb3 integrin,
upregulated on activated macrophages. ApoE-/- mice
(N=4) were injected intravenously with RGD+P22 or RGD-
P22 (labeled with Cy5.5, 4 nmol/mouse). Forty-eight hours
later, ex vivo fluorescence imaging was performed using
MaestroTM imaging system (Cri, Woburn, MA). Maxi-
mum plaque signal intensities were measured and
compared.
Results
Low dose P22-polymer-Gd showed strong enhancement
for 1T vascular MRA (Figure 2). It also showed clear
enhancement of the aortic wall (ApoE-/-) and ligated caro-
tid (FVB) at 3T (Figure 3). Ex vivo fluorescence imaging
showed the accumulation of both RGD+P22 or RGD-P22
in atherosclerotic lesions (Figure 4). RDG targeting
enhanced plaque uptake (RGD+P22: 0.025 ± 0.002 counts/
sec vs. RGD-P22: 0.005 ± 0.004 counts/sec, p=0.05).
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Conclusions
The P22 protein cage nanoparticle demonstrates both
internal high-relaxivity Gd-loading for in vivo MRI as well
as external RGD-targeting for enhanced uptake in vascular
inflammation. Thus, P22 is a novel, multi-functional nano-
particle platform for targeted-imaging of atherosclerosis.
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